SEARCH

SEARCH BY CITATION

References

  • 1
    Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer 2006; 118: 30303044.
  • 2
    WHO Expert Committee. Prevention and Control of Schistosomiasis and Soil-Transmitted Helminthiases. Technical report Series. Geneva, World Health Organization, 2002.
  • 3
    Sripa B, Kaewkes S, Sithithaworn P, et al. Liver fluke induces cholangiocarcinoma. PLoS Med 2007; 4: e201.
  • 4
    Mayer DA & Fried B. The role of helminth infections in carcinogenesis. Adv Parasitol 2007; 65: 239296.
  • 5
    Mostafa MH, Sheweita SA & O’Connor PJ. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev 1999; 12: 97111.
  • 6
    Herrera LA & Ostrosky-Wegman P. Do helminths play a role in carcinogenesis? Trends Parasitol 2001; 17: 172175.
  • 7
    Bouvarda V, Baana R, Straifa K, et al. A review of human carcinogens – part B: biological agents. Lancet Oncol 2009; 10: 321322.
  • 8
    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 24 February–3 March 2009. Schistosoma haematobium, liver flukes and Heliobacter pylori. IARC Monogr Eval Carcinog Risks Hum 2009; 100 (in press).
  • 9
    Coussens LM & Werb Z. Inflammation and cancer. Nature 2002; 420: 860867.
  • 10
    Shacter E & Weitzman SA. Chronic inflammation and cancer. Oncology 2002; 16: 217222.
  • 11
    Herrera LA, Ramirez T, Rodríguez U, et al. Possible association between Taenia solium cysticercosis and cancer: increased frequency of DNA damage in peripheral lymphocytes from neurocysticercosis patients. Trans R Soc Trop Med Hyg 2000; 94: 6165.
  • 12
    Hudson JD, Shoaibi MA, Maestro R, Carnero A, Hannon GJ & Beach DH. A proinflammatory cytokine inhibits p53 tumour suppressor activity. J Exp Med 1999; 190: 13751382.
  • 13
    Pettit SJ, Seymour K, O’Flaherty E & Kirby JA. Immune selection in neoplasia: towards a microevolutionary model of cancer development. Br J Cancer 2000; 82: 19001906.
  • 14
    Rubin B. Natural immunity has significant impact on immune responses against cancer. Scand J Immunol 2009; 69: 275290.
  • 15
    Chang CC & Ferrone S. Immune selective pressure and HLA class I antigen defects in malignant lesions. Cancer Immunol Immunother 2007; 56: 22736.
  • 16
    Tan TT & Coussens LM. Humoral immunity, inflammation and cancer. Curr Opin Immunol 2007; 19: 209216.
  • 17
    Hoffmann KF, Wynn TA & Dunne DW. Cytokine-mediated host responses during schistosome infections; walking the fine line between immunological control and immunopathology. Adv Parasitol 2002; 52: 265307.
  • 18
    Dunne DW & Cooke A. A worm’s eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol 2005; 5: 420426.
  • 19
    Gryseels B, Polman K, Clerinx J & Kestens L. Human schistosomiasis. Lancet 2006; 368: 11061118.
  • 20
    Burke ML, Jones MK, Gobert GN, Li YS, Ellis MK & McManus DP. Immunopathogenesis of human schistosomiasis. Parasite Immunol 2009; 31: 163176.
  • 21
    Ross AG, Bartley PB, Sleigh AC, et al. Schistosomiasis. N Engl J Med 2002; 346: 12121220.
  • 22
    Strickland GT. Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 2006; 43: 915922.
  • 23
    Wilson MS, Mentink-Kane MM, Pesce JT, Ramalingam TR, Thompson R & Wynn TA. Immunopathology of schistosomiasis. Immunol Cell Biol 2007; 85: 148154.
  • 24
    Pearce EJ, Kane CM, Sun J, Taylor JJ, McKee AS & Cervi L. Th2 response polarization during infection with the helminth parasite Schistosoma mansoni. Immunol Rev 2004; 201: 117126.
  • 25
    Leutscher P, Ramarokoto CE, Reimert C, Feldmeier H, Esterre P & Vennervald BJ. Community-based study of genital schistosomiasis in men from Madagascar. Lancet 2000; 355: 117118.
  • 26
    Poggensee G, Kiwelu I, Weger V, et al. Female genital schistosomiasis of the lower genital tract: prevalence and disease-associated morbidity in northern Tanzania. J Infect Dis 2000; 181: 12101213.
  • 27
    Kjetland EF, Ndhlovu PD, Mduluza T, et al. Simple clinical manifestations of genital Schistosoma haematobium infection in rural Zimbabwean women. Am J Trop Med Hyg 2005; 72: 311319.
  • 28
    Chen MG & Mott KE. Progress in the assessment of morbidity in Schistosoma haematobium: a review of the recent literature. Trop Dis Bull 1989; 48: 26432648.
  • 29
    Groeneveld AE, Marszalek WW & Heyns CF. Bladder cancer in various population groups in the greater Durban area of Kwazulu-Natal, South Africa. Br J Urol 1996; 78: 205208.
  • 30
    Mustacchi P & Shimkin MS. Cancer of the bladder and infestation with Schistosoma hematobium. J Natl Cancer Inst 1958; 20: 825242.
  • 31
    Gelfand M, Weinberg RW & Castle WM. Relation between carcinoma of the bladder and infestation with Schistosoma haematobium. Lancet 1967; I: 12491251.
  • 32
    Elem B & Purohit R. Carcinoma of the urinary bladder in Zambia. A quantitative estimation of Schistosoma haematobium infection. Br J Urol 1983; 55: 275278.
  • 33
    Skinner MEG, Parkin DM, Vizcaino AP & Ndhlovu A. Cancer in the African Population of Bulawayo, Zimbabwe, 1963–1977, Incidence, Time, Trends and Risk Factors (IARC Technical Report No. 15). Lyon, IARC, 1993.
  • 34
    Parkin DM, Vizcaino AP, Skinner MEG & Ndhlovu A. Cancer patterns and risk factors in the African population of Southwestern Zimbabwe, 1963–1977. Cancer Epidemiol Biomarkers Prev 1994; 3: 537547.
  • 35
    Vizcaino AP, Parkin DM, Boffetta P & Skinner MEG. Bladder cancer: epidemiology and risk factors in Bulawayo, Zimbabwe. Cancer Causes and Control 1994; 5: 517522.
  • 36
    Bedwani R, Renganathan E, El Kwhsky F, et al. Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer 1998; 77: 11861189.
  • 37
    Moubayed P, Ziehe A, Peters J, Mwakyoma H & Schmidt D. Carcinoma of the uterine cervix associated with schistosomiasis and induced by human papillomaviruses. Int J Gynaecol Obstet 1995; 49: 175179.
  • 38
    Riffenburgh RH, Olson PE & Johnstone PA. Association of schistosomiasis with cervical cancer: detecting bias in clinical studies. East Afr Med J 1997; 74: 1416.
  • 39
    Petry KU, Scolz U, Hollwitz B, Von Wasielewski R & Meijer CJLM. Human papillomavirus, coinfection with Schistosoma hematobium, and cervical neoplasia in rural Tanzania. Int J Gynaecol Cancer 2003; 13: 505509.
  • 40
    Poggensee G & Feldmeier H. Female genital schistosomiasis: facts and hypotheses. Acta Trop 2001; 79: 193210.
  • 41
    Mostafa MH, Sheweita SA & O’Connor PJ. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev 1999; 12: 97111.
  • 42
    Hicks RM, James C & Webbe G. Effect of Schistosoma haematobium and N-butyl-N-(4-hydroxybutyl)nitrosamine on the development of urothelial neoplasia in the baboon. Br J Cancer 1980; 42: 730755.
  • 43
    Rosin MP, Anwar WA & Ward AJ. Inflammation, chromosomal instability, and cancer: the schistosomiasis model. Cancer Res 1994; 54: 19291933.
  • 44
    Rosin MP, Saad el Din ZS, Ward AJ & Anwar WA. Involvement of inflammatory reactions and elevated cell proliferation in the development of bladder cancer in schistosomiasis patients. Mutat Res 1994; 305: 283292.
  • 45
    Badawi AF. Molecular and genetic events in schistosomiasis-associated human bladder cancer: role of oncogenes and tumor suppressor genes. Cancer Lett 1996; 105: 123138.
  • 46
    Michaud DS. Chronic inflammation and bladder cancer. Urol Oncol 2007; 25: 260268.
  • 47
    Eltoum IA, Suliaman SM, Ismail BM, Ismail AI, Ali MM & Homeida MM. Evaluation of eosinophiluria in the diagnosis of schistosomiasis hematobium: a field-based study. Am J Trop Med Hyg 1992; 46: 732736.
  • 48
    Reimert CM, Mshinda HM, Hatz CF, et al. Quantitative assessment of eosinophiluria in Schistosoma haematobium infections: a new marker of infection and bladder morbidity. Am J Trop Med Hyg 2000; 62: 1928.
  • 49
    Leutscher PD, Reimert CM, Vennervald BJ, et al. Morbidity assessment in urinary schistosomiasis infection through ultrasonography and measurement of eosinophil cationic protein (ECP) in urine. Trop Med Int Health 2000; 5: 8893.
  • 50
    Abdel Mohsen MA, Hassan AA, El-Sewedy SM, et al. Biomonitoring of n-nitroso compounds, nitrite and nitrate in the urine of Egyptian bladder cancer patients with or without Schistosoma haematobium infection. Int J Cancer 1999; 82: 789794.
  • 51
    Badawi AF, Mostafa MH, Probert A & O’Connor PJ. Role of schistosomiasis in human bladder cancer: evidence of association, aetiological factors, and basic mechanisms of carcinogenesis. Eur J Cancer Prev 1995; 4: 4559.
  • 52
    Badawi AF, Mostafa MH, Aboul-Azm T, Haboubi NY, O’Connor PJ & Cooper DP. Promutagenic methylation damage in bladder DNA from patients with bladder cancer associated with schistosomiasis and from normal individuals. Carcinogenesis 1992; 13: 877881.
  • 53
    Badawi AF, Cooper DP, Mostafa MH, et al. O6-alkylguanine-DNA alkyltransferase activity in schistosomiasis-associated human bladder cancer. Eur J Cancer 1994; 30A: 13141319.
  • 54
    Saad AA, O’Connor PJ, Mostafa MH, et al. Bladder tumor contains higher N7-methylguanine levels in DNA than adjacent normal bladder epithelium. Cancer Epidemiol Biomarkers Prev 2006; 15: 740743.
  • 55
    Gutiérrez MI, Siraj AK, Khaled H, Koon N, El-Rifai W & Bhatia K. CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer. Mod Pathol 2004; 17: 12681274.
  • 56
    Habuchi T, Takahashi R, Yamada H, et al. Influence of cigarette smoking and schistosomiasis on p53 gene mutation in urothelial cancer. Cancer Res 1993; 53: 37953799.
  • 57
    Ramchurren N, Cooper K & Summerhayes IC. Molecular events underlying schistosomiasis-related bladder cancer. Int J Cancer 1995; 62: 237244.
  • 58
    Tamimi Y, Bringuier PP, Smit F, et al. Homozygous deletions of p16(INK4) occur frequently in bilharziasis-associated bladder cancer. Int J Cancer 1996; 68: 183187.
  • 59
    Salim EI, Morimura K, Menesi A, El-Lity M, Fukushima S & Wanibuchi H. Elevated oxidative stress and DNA damage and repair levels in urinary bladder carcinoma associated with schistosomiasis. Int J Cancer 2008; 123: 601608.
  • 60
    Chaudhary KS, Lu QL, Abel PD, et al. Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder. Br J Urol 1997; 79: 7884.
  • 61
    Swellam M, Abd-Elmaksoud N, Halim MH, Khatab H & Khiry H. Incidence of Bcl-2 expression in bladder cancer: relation to schistosomiasis. Clin Biochem 2004; 37: 798802.
  • 62
    Hodder SL, Mahmoud AA, Sorenson K, et al. Predisposition to urinary tract epithelial metaplasia in Schistosoma haematobium infection. Am J Trop Med Hyg 2000; 63: 133138.
  • 63
    Shiff C, Veltri R, Naples J, et al. Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with Schistosoma haematobium in Ghana. Trans R Soc Trop Med Hyg 2006; 100: 847885.
  • 64
    Eissa S, Swellam M, Ali-Labib R, Mansour A, El-Malt O & Tash FM. Detection of telomerase in urine by 3 methods: evaluation of diagnostic accuracy for bladder cancer. J Urol 2007; 178: 10681072.
  • 65
    King CL. Initiation and regulation of disease in schistosomiasis. In MahmoudAA (ed): Schistosomiasis. London, Imperial College Press, 2001: 213264.
  • 66
    Olveda RM. Disease in schistosomiasis japonica. In: MahmoudAA (ed): Schistosomiasis. London, Imperial College Press, 2001: 361389.
  • 67
    IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7–14 June 1994. Schistosomes, liver flukes and Heliobacter pylori. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1241.
  • 68
    Bacelar A, Castro LGMC, Cheto de Queiroz A & Café E. Association between prostate cancer and schistosomiasis in young patients: a case report and literature review. Braz J Infect Dis 2007; 11: 520522.
  • 69
    Andrade ZA & Abreu WN. Follicular lymphoma of the spleen in patients with hepatosplenic Schistosomiasis mansoni. Am J Trop Med Hyg 1971; 20: 237243.
  • 70
    De Andrade DR, Ishioka S, Câmara-Lopes LH & Meira JA. Association of hepatosplenic schistosomiasis mansoni and histiocytic lymphoma. Arq Gastroenterol 1982; 19: 7780. Portuguese.
  • 71
    Habib SL, Said B, Awad AT, Mostafa MH & Shank RC. Novel adenine adducts, N7-guanine-AFB1 adducts, and p53 mutations in patients with schistosomiasis and aflatoxin exposure. Cancer Detect Prev 2006; 30: 491498.
  • 72
    Dimmette RM, Elwi AM & Spratt HF. Relationship of schistosomiasis to polyposis and adenocarcinoma of the large intestine. Am J Clin Pathol 1959; 26: 266276.
  • 73
    Qiu DC, Hubbard AE, Zhong B, Zhang Y & Spear RC. A matched, case-control study of the association between Schistosoma japonicum and liver and colon cancers, in rural China. Ann Trop Med Parasitol 2005; 99: 4752.
  • 74
    Ishii A, Matsuoka H, Aji T, et al. Parasite infection and cancer: with special emphasis on Schistosoma japonicum infections (Trematoda). A review. Mutat Res 1994; 305: 273281.
  • 75
    Matsuoka H, Aji T, Ishii A, Arimoto S, Wataya Y & Hayatsu H. Reduced levels of mutagen processing potential in the Schistosoma japonicum-infected mouse liver. Mutat Res 1989; 227: 153157.
  • 76
    Arimoto S, Matsuoka H, Aji T, Ishii A, Wataya Y & Hayatsu H. Modified metabolism of a carcinogen, 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2), by liver S9 from Schistosoma japonicum-infected mice. Mutat Res 1992; 282: 177182.
  • 77
    Aji T, Matsuoka H, Ishii A, Arimoto S & Hayatsu H. Retention of a mutagen, 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2), in the liver of mice infected with Schistosoma japonicum. Mutat Res 1994; 305: 265272.
  • 78
    Zhang R, Takahashi S, Orita S, et al. p53 gene mutations in rectal cancer associated with schistosomiasis japonica in Chinese patients. Cancer Lett 1998; 131: 215221.
  • 79
    Keiser J & Utzinger J. Emerging foodborne trematodiasis. Emerg Infect Dis 2005; 11: 15071514.
  • 80
    Kim TS, Cho SH, Huh S, et al. A nationwide survey on the prevalence of intestinal parasitic infections in the Republic of Korea, 2004. Korean J Parasitol 2009; 47: 3747.
  • 81
    Cho SH, Lee KY, Lee BC, et al. Prevalence of clonorchiasis in southern endemic areas of Korea in 2006. Korean J Parasitol 2008; 46: 133137.
  • 82
    WHO. Control of food borne trematode infections. Report of a WHO Study group. World Health Organ Tech Rep Ser 1995; 849: 1157.
  • 83
    Jongsuksuntigul P & Imsomboon T. Opisthorchiasis control in Thailand. Acta Trop 2003; 88: 229232.
  • 84
    Kaewpitoon N, Kaewpitoon SJ & Pengsaa P. Opisthorchiasis in Thailand: review and current status. World J Gastroenterol 2008; 14: 22972302.
  • 85
    Bhamarapravati N, Thammavit W & Vajrasthira S. Liver changes in hamsters infected with a liver fluke of man, Opisthorchis viverrini. Am J Trop Med Hyg 1978; 27: 787794.
  • 86
    Rim HJ. The current pathobiology and chemotherapy of clonorchiasis. Kisaengchunghak Chapchi 1986; 24 (Suppl.): 1141.
  • 87
    Sripa B. Pathobiology of opisthorchiasis: an update. Acta Trop 2003; 88: 209220.
  • 88
    Rim HJ. Clonorchiasis: an update. J Helminthol 2005; 79: 269281.
  • 89
    Lim JH, Mairiang E & Ahn GH. Biliary parasitic diseases including clonorchiasis, opisthorchiasis and fascioliasis. Abdom Imaging 2008; 33: 157165.
  • 90
    Chai JY, Park JH, Han ET, et al. Mixed infections with Opisthorchis viverrini and intestinal flukes in residents of Vientiane Municipality and Saravane Province in Laos. J Helminthol 2005; 79: 283289.
  • 91
    Sithithaworn P, Haswell-Elkins MR, Mairiang P, et al. Parasite-associated morbidity: liver fluke infection and bile duct cancer in northeast Thailand. Int J Parasitol 1994; 24: 833843.
  • 92
    Marcos LA, Terashima A & Gotuzzo E. Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr Opin Infect Dis 2008; 21: 523530.
  • 93
    Lim JH. Radiologic findings of clonorchiasis. AJR Am J Roentgenol 1990; 155: 10011008.
  • 94
    Lun ZR, Gasser RB, Lai DH, et al. Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis 2005; 5: 3141.
  • 95
    Sripa B & Pairojkul C. Cholangiocarcinoma: lessons from Thailand. Curr Opin Gastroenterol 2008; 24: 349356.
  • 96
    Caldwell S & Park SH. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol 2009; 44 (Suppl. 19): 96101.
  • 97
    Gomaa AI, Khan SA, Toledano MB, Waked I & Taylor-Robinson SD. Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 2008; 14: 43004308.
  • 98
    Srivatanakul P, Sriplung H & Deerasamee S. Epidemiology of liver cancer: an overview. Asian Pac J Cancer Prev 2004; 5: 118125.
  • 99
    Shin EH, Guk SM, Kim HJ, Lee SH & Chai JY. Trends in parasitic diseases in the Republic of Korea. Trends Parasitol 2008; 24: 143150.
  • 100
    Kim HG, Han J, Kim MH, et al. Prevalence of clonorchiasis in patients with gastrointestinal disease: a Korean nationwide multicenter survey. World J Gastroenterol 2009; 15: 8694.
  • 101
    Lim MK, Ju YH, Franceschi S, et al. Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea. Am J Trop Med Hyg 2006; 75: 9396.
  • 102
    Shin HR, Lee CU, Park HJ, et al. Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol 1996; 25: 933940.
  • 103
    Choi D, Lim JH, Lee KT, et al. Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea. J Hepatol 2006; 44: 10661073.
  • 104
    Lee TY, Lee SS, Jung SW, et al. Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: a case-control study. Am J Gastroenterol 2008; 103: 17161720.
    Direct Link:
  • 105
    Sriplung H, Sontipong S, Martin N, et al. Cancer incidence in Thailand, 1995–1997. Asian Pac J Cancer Prev 2005; 6: 276281.
  • 106
    Vatanasapt V, Tangvoraphonkchai V, Titapant V, Pipitgool V, Viriyapap D & Sriamporn S. A high incidence of liver cancer in Khon Kaen Province, Thailand. Southeast Asian J Trop Med Public Health 1990; 21: 489494.
  • 107
    Vatanasapt V, Uttaravichien T, Mairiang EO, Pairojkul C, Chartbanchachai W & Haswell-Elkins M. Cholangiocarcinoma in north-east Thailand. Lancet 1990; 335: 116117.
  • 108
    Kurathong S, Lerdverasirikul P, Wongpaitoon V, et al. Opisthorchis viverrini infection and cholangiocarcinoma. A prospective, case-controlled study. Gastroenterology 1985; 89: 151156.
  • 109
    Parkin DM, Srivatanakul P, Khlat M, et al. Liver cancer in Thailand. I. A case-control study of cholangiocarcinoma. Int J Cancer 1991; 48: 323328.
  • 110
    Haswell-Elkins MR, Mairiang E, Mairiang P, et al. Cross-sectional study of Opisthorchis viverrini infection and cholangiocarcinoma in communities within a high-risk area in northeast Thailand. Int J Cancer 1994; 59: 505509.
  • 111
    Honjo S, Srivatanakul P, Sriplung H, et al. Genetic and environmental determinants of risk for cholangiocarcinoma via Opisthorchis viverrini in a densely infested area in Nakhon Phanom, northeast Thailand. Int J Cancer 2005; 117: 854860.
  • 112
    Flavell DJ & Lucas SB. Promotion of N-nitrosodimethylamine-initiated bile duct carcinogenesis in the hamster by the human liver fluke, Opisthorchis viverrini. Carcinogenesis 1983; 4: 927930.
  • 113
    Flavell DJ & Lucas SB. Potentiation by the human liver fluke, Opisthorchis viverrini, of the carcinogenic action of N-nitrosodimethylamine upon the biliary epithelium of the hamster. Br J Cancer 1982; 46: 985989.
  • 114
    Thamavit W, Bhamarapravati N, Sahaphong S, Vajrasthira S & Angsubhakorn S. Effects of dimethylnitrosamine on induction of cholangiocarcinoma in Opisthorchis viverrini-infected Syrian golden hamsters. Cancer Res 1978; 38: 46344639.
  • 115
    Thamavit W, Pairojkul C, Tiwawech D, Itoh M, Shirai T & Ito N. Promotion of cholangiocarcinogenesis in the hamster liver by bile duct ligation after dimethylnitrosamine initiation. Carcinogenesis 1993; 14: 24152417.
  • 116
    Thamavit W, Pairojkul C, Tiwawech D, Shirai T & Ito N. Strong promoting effect of Opisthorchis viverrini infection on dimethylnitrosamine-initiated hamster liver. Cancer Lett 1994; 78: 121125.
  • 117
    Thamavit W, Tiwawech D, Moore MA, Ito N & Shirai T. Equivocal evidence of complete carcinogenicity after repeated infection of Syrian hamsters with Opisthorchis viverrini. Toxicol Pathol 1996; 24: 493497.
  • 118
    Lee JH, Rim HJ & Bak UB. Effect of Clonorchis sinensis infection and dimethylnitrosamine administration on the induction of cholangiocarcinoma in Syrian golden hamsters. Korean J Parasitol 1993; 31: 2130.
  • 119
    Lee JH, Yang HM, Bak UB & Rim HJ. Promoting role of Clonorchis sinensis infection on induction of cholangiocarcinoma during two-step carcinogenesis. Korean J Parasitol 1994; 32: 1318.
  • 120
    Jang JJ, Cho KJ, Myong NH & Chai JY. Enhancement of dimethylnitrosamine-induced glutathione S-transferase P-positive hepatic foci by Clonorchis sinensis infestation in F344 rats. Cancer Lett 1990; 52: 133138.
  • 121
    Sohn WM, Zhang H, Choi MH & Hong ST. Susceptibility of experimental animals to reinfection with Clonorchis sinensis. Korean J Parasitol 2006; 44: 163166.
  • 122
    Thuwajit C, Thuwajit P, Kaewkes S, et al. Increased cell proliferation of mouse fibroblast NIH-3T3 in vitro induced by excretory/secretory product(s) from Opisthorchis viverrini. Parasitology 2004; 129: 455464.
  • 123
    Thuwajit C, Thuwajit P, Uchida K, et al. Gene expression profiling defined pathways correlated with fibroblast cell proliferation induced by Opisthorchis viverrini excretory/secretory product. World J Gastroenterol 2006; 12: 35853592.
  • 124
    Kim YJ, Choi MH, Hong ST & Bae YM. Proliferative effects of excretory/secretory products from Clonorchis sinensis on the human epithelial cell line HEK293 via regulation of the transcription factor E2F1. Parasitol Res 2008; 102: 411417.
  • 125
    Sripa B & Kaewkes S. Localisation of parasite antigens and inflammatory responses in experimental opisthorchiasis. Int J Parasitol 2000; 30: 735740.
  • 126
    Pinlaor S, Hiraku Y, Ma N, et al. Mechanism of NO-mediated oxidative and nitrative DNA damage in hamsters infected with Opisthorchis viverrini: a model of inflammation-mediated carcinogenesis. Nitric Oxide 2004; 11: 175183.
  • 127
    Pinlaor S, Yongvanit P, Hiraku Y, et al. 8-nitroguanine formation in the liver of hamsters infected with Opisthorchis viverrini. Biochem Biophys Res Commun 2003; 309: 567571.
  • 128
    Jaiswal M, LaRusso NF, Burgart LJ & Gores GJ. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res 2000; 60: 184190.
  • 129
    Jaiswal M, LaRusso NF, Shapiro RA, Billiar TR & Gores GJ. Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes. Gastroenterology 2001; 120: 190199.
  • 130
    Kawanishi S, Hiraku Y, Pinlaor S & Ma N. Oxidative and nitrative DNA damage in animals and patients with inflammatory diseases in relation to inflammation-related carcinogenesis. Biol Chem 2006; 387: 365372.
  • 131
    Kawanishi S & Hiraku Y. Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxid Redox Signal 2006; 8: 10471058.
  • 132
    Sirica AE. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology 2005; 41: 515.
  • 133
    Sripa B, Leungwattanawanit S, Nitta T, et al. Establishment and characterization of an opisthorchiasis-associated cholangiocarcinoma cell line (KKU-100). World J Gastroenterol 2005; 11: 33923397.
  • 134
    Tsocheva NT, Kadiiska MB, Poljakova-Krusteva OT, Krustev LP, Yanev SS & Stoytchev TS. Combined effect of fascioliasis and diethylnitrosamine carcinogenesis on the activity of the rat liver monooxygenase system. Comp Biochem Physiol C 1992; 101: 475479.
  • 135
    Montero R, Gentile GJ, Frederick L, et al. Induced expression of CYP2A5 in inflamed trematode-infested mouse liver. Mutagenesis 1999; 14: 217220.
  • 136
    Motorna OO, Martin H, Gentile GJ & Gentile JM. Analysis of lacI mutations in Big Blue transgenic mice subjected to parasite-induced inflammation. Mutat Res 2001; 484: 6976.
  • 137
    Molinari JL, Mejia H, White AC Jr, et al. Taenia solium: a cysteine protease secreted by metacestodes depletes human CD4 lymphocytes in vitro. Exp Parasitol 2000; 94: 133142.
  • 138
    Herrera LA, Tato P, Molinari JL, Pérez E, Domínguez H & Ostrosky-Wegman P. Induction of DNA damage in human lymphocytes treated with a soluble factor secreted by Taenia solium metacestodes. Teratog Carcinog Mutagen 2003; 23 (Suppl. 1): 7983.
  • 139
    Silva LP, Costa-Cruz JM, Spanó MA & Graf U. Genotoxicity of vesicular fluid and saline extract of Taenia solium metacestodes in somatic cells of Drosophila melanogaster. Environ Mol Mutagen 2006; 47: 247253.
  • 140
    Huby F, Nano JL, Mallet S & Hoste H. Effects of the excretory/secretory products of Trichostrongylus colubriformis on the growth of different cell lines. Int J Parasitol 1999; 29: 697702.
  • 141
    Huby F, Hoste H, Mallet S, Fournel S & Nano JL. Effects of the excretory/secretory products of six nematode species, parasites of the digestive tract, on the proliferation of HT29-D4 and HGT-1 cell lines. Epithelial Cell Biol 1995; 4: 156162.
  • 142
    Gabet AS, Mortreux F, Talarmin A, et al. High circulating proviral load with oligoclonal expansion of HTLV-1 bearing T cells in HTLV-1 carriers with strongyloidiasis. Oncogene 2000; 19: 49544960.
  • 143
    Hussain SP & Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 2007; 121: 23732380.
  • 144
    Balkwill F & Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539545.
  • 145
    Sitas F, Parkin DM, Chirenje M, Stein L, Abratt R & Wabinga H. Part II: cancer in Indigenous Africans – causes and control. Lancet Oncol 2008; 9: 786795.
  • 146
    Koraitim MM, Metwalli NE, Atta MA & El-Sadr AA. Changing age incidence and, pathological types of schistosoma-associated bladder carcinoma. J Urol 1995; 154: 17141716.